Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosis

Even with treatment of HIV with antiretroviral therapy (ART), the risk of tuberculosis (TB) reactivation remains higher in HIV-infected than HIV-uninfected persons. In this issue of the JCI, Ganatra et al. explored TB reactivation in the context of ART using TB and simian immunodeficiency virus-coin...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of clinical investigation Vol. 130; no. 10; pp. 5102 - 5104
Main Authors:	Sterling, Timothy R., Lin, Philana Ling
Format:	Journal Article
Language:	English
Published:	United States American Society for Clinical Investigation 01.10.2020
Subjects:	Animals Antiretroviral agents CD4-Positive T-Lymphocytes Comorbidity Drug therapy Health aspects Highly active antiretroviral therapy HIV Infections - complications HIV Infections - drug therapy Macaca mulatta Monkeys Rifamycins Rifapentine Simian Acquired Immunodeficiency Syndrome - drug therapy Simian Immunodeficiency Virus T cells Tuberculosis Tuberculosis - drug therapy Tuberculosis - prevention & control
ISSN:	0021-9738, 1558-8238, 1558-8238
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!